BRIC CGM Market, Forecast By Renub Research

The BRIC CGM market witnessed strong growth in recent decades and is further expected to grow primarily due to the increasing adaptation of continuous glucose monitoring devices in China and India. This rising diabetic population in Brazil, Russia, India, and China and increasing the adoption of CGM devices and Continuous Positive Cost-Effective Analysis by BRIC Countries will propel the growth of the BRIC CGM market. China has the largest market share in 2019; while, India is foreseen to witness a significant market share during the forecast period. According to Renub Research analysis, the BRIC CGM Market will reach US$ 868 Million by the end of the year 2025.

The BRIC CGM market is driven mainly by the increasing numbers of people with diabetes across BRIC countries, growing diabetes research, and increasing international research collaborations. The Continuous Positive Cost-Effective Analysis by BRICS Countries and rapid urbanization and CGM Technology Convenient for both Patients & Physicians are further expected to contribute to the growth of this CGM market. However, Controversy regarding Clinical Benefits and the high cost of diabetes care devices are the remonstrance growth of this market.

BRIC CGM Market, Forecast By Users, & CGM Components

In the year Feb 2019, Senseonics made a distribution agreement with Roche Diabetes Care for two years, giving exclusive rights to the Big Biotech for selling implantable glucose monitoring systems in Brazil, Russia, India, and China. The continuous glucose monitoring (CGM) devices market in BRIC countries are set to thrive regardless of the major upheaval caused by the COVID-19 pandemic. The surging demand for CGM in BRIC countries are primarily driven by a growing awareness of the devices and companies’ quick responses to the COVID-19 epidemic.

Diabetes could be a clinical condition where the inability of the pancreas to supply insulin causes the glucose level within the body to increase. The factors accountable for the increasing incidence of diabetes is the lack of physical activity, the harmful use of alcohol, tobacco consumption, and obesity. The key factor driving the market growth is the increasing geriatric population susceptible to various chronic diseases. Consistent with the United Nation statistics, the quantity of BRIC population older than 65 years is predicted to succeed in 295 million by 2020 and 412 million by 2030.

Increasing healthcare expenditure is additionally anticipated to fuel the market for diabetes care devices within the BRIC nations. for example, Brazil’s healthcare spending per GDP is anticipated to increase from 8.3% in 2014 to 10.0% in 2030. Several Gov. initiatives and products launches within the field of diabetes care are expected to propel market growth. For example, in 2019, Research Trust of Diabetes India launched its 1000 days Initiative to manage diabetes within the country. This initiative is predicted to bring diabetologists across the country to supply recommendations and clinical guidelines.

Renub Research latest study “BRIC CGM Market, Users, Reimbursement Policy, CGM Components (Glucose Sensor, Transmitter) Market, Diabetes (Type1 & 2) Population, & Forecast” provides a detailed and comprehensive insight of the BRIC CGM Market.

• CGM Market
• CGM Users
• CGM Reimbursements Policy

Request a free Sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=bric-cgm-market-p.php

Scope of the Report

• CGM Market & Forecast: In this report, we have fragmented the CGM market into two parts; CGM transmitter market and CGM Sensor Market. We have cover 4 countries along with growth factors.

• CGM Users & Forecast: We have computed CGM user of top 4 countries. Historical data is computed from 2011-2019, and forecast data would be shown from 2020-2025.

• Reimbursement Policy: This report provides a changing picture of Reimbursement Policy on CGM (Continuous Glucose Monitoring) BRIC and country wise. Reimbursement model of BRIC that will give the overall situation of CGM acceptance across private and public hospitals and insurer.

• Diabetes Population: Report covers population & forecast of 4 (Type 1 and Type 2 diabetes)

• Growth Factors for CGM: This report studies the key factor that would help the CGM industry to outperform.

• Challenges for CGM: This industry shows the problems being faced by the CGM technology and industry.

Countries Covered

1.    Brazil
2.    Russia
3.    India
4.    China

About Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises of major players in Life Sciences, Information Technology, Telecom, Financial Services (Banking, Insurance), Energy, Retail, Manufacturing, Automotive, and Social sector. Our clients rely on our market analysis and data to make informed knowledgeable decisions. We are regarded as one of the best providers of knowledge. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.

Contact Us:
Renub Research
Phone No: +1 678-302-0700 (USA) | +91-120-421-9822 (IND)
Email: info@renub.com
Web: https://www.renub.com
Follow on Linkedin: https://www.linkedin.com/company/renub-research

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s